Skip to main content
. 2017 Feb 2;27(4):1115–1118. doi: 10.1007/s11695-017-2576-y

Table 1.

Clinical characteristics. Values are mean ± SD. Analyzed with unpaired t test. Baseline characteristics have previously been published [1, 5]

Baseline 5-year follow-up
Non-omentectomy Omentectomy P value Non-omentectomy Omentectomy P value
N 41 40 23 26
Age (years) 41 ± 9 43 ± 9 0.42 48 ± 10 49 ± 9 0.72
Weight (kg) 119 ± 16 121 ± 15 0.52 85 ± 16 85 ± 19 0.94
BMI (kg/m2) 43.1 ± 5.4 44.3 ± 4.7 0.27 30.7 ± 5.2 31.4 ± 6.0 0.67
Waist to hip ratio 1.00 ± 0.07 1.00 ± 0.06 0.64 0.93 ± 0.07 0.92 ± 0.08 0.85
Total body fat % 53 ± 4 54 ± 3 0.41 43 ± 7 43 ± 8 0.93
Estimated visceral adipose tissue (kg) 2.39 ± 0.87 2.35 ± 0.78 0.84 0.90 ± 0.55 0.91 ± 0.66 0.98
Estimated subcutaneous adipose tissue (kg) 3.93 ± 1.00 3.89 ± 1.39 0.90 2.07 ± 1.07 2.35 ± 1.34 0.41
Systolic blood pressure (mmHg) 133 ± 17 137 ± 17 0.23 125 ± 14 134 ± 22 0.09
Diastolic blood pressure (mmHg) 84 ± 9 85 ± 8 0.67 76 ± 9 82 ± 10 0.03
P-glucose (mmol/L) 5.5 ± 1.1 5.6 ± 1.3 0.77 5.0 ± 0.7 5.0 ± 0.6 0.82
P-insulin (mU/l) 14.7 ± 7.5 18.2 ± 9.4 0.07 5.2 ± 2.4 6.2 ± 2.8 0.15
P-cholesterol (mmol/l) 4.8 ± 0.9 4.9 ± 0.9 0.62 4.2 ± 0.9 4.3 ± 0.8 0.73
P-HDL cholesterol (mmol/l) 1.1 ± 0.2 1.2 ± 0.3 0.55 1.6 ± 0.4 1.6 ± 0.5 0.57
P-triglycerides (mmol/l) 1.5 ± 0.7 1.5 ± 0.7 0.93 1.0 ± 0.6 0.9 ± 0.3 0.65
P-NEFA (mmol/l) 0.75 ± 0.24 0.81 ± 0.17 0.22 0.6 ± 0.3 0.7 ± 0.3 0.52
P-apolipoprotein B (g/l) 0.91 ± 0.23 0.97 ± 0.25 0.28 0.82 ± 0.22 0.83 ± 0.22 0.83
P-apolipoprotein A1 (g/l) 1.22 ± 0.20 1.23 ± 0.22 0.85 1.56 ± 0.33 1.55 ± 0.37 0.89
P-alanine aminotransferase (U/L) 34.2 ± 17.6 34.6 ± 16.5 0.91 19.7 ± 7.2 18.2 ± 6.8 0.46
P-aspartate aminotransferase (U/L) 28.9 ± 12.6 31.0 ± 11.9 0.45 22.7 ± 4.5 23.1 ± 8.1 0.81